Noah L. Rosenberg Insider Trading $RTRX Travere Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Noah L. Rosenberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Noah L. Rosenberg. Noah L. Rosenberg is Chief Medical Officer in Retrophin, Inc. ($RTRX) and Chief Medical Officer in Esperion Therapeutics, Inc. ($ESPR).
Noah L. Rosenberg in Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Noah L. Rosenberg: Chief Medical Officer
Holdings: 45,969 shares
Current Value: $922,598
Latest Transaction: May 13 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Noah L. Rosenberg in Travere Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.46 | 375 | 7,298 | 45,594 | 46 K to 45.6 K (-0.82 %) |
| May 13 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.14 | 375 | 7,178 | 45,969 | 46.3 K to 46 K (-0.81 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 31.58 | 1,125 | 35,528 | 46,344 | 47.5 K to 46.3 K (-2.37 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 31.41 | 1,125 | 35,336 | 47,469 | 48.6 K to 47.5 K (-2.32 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 4,500 | 0 | 48,594 | 44.1 K to 48.6 K (+10.21 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 4,500 | 0 | 48,594 | 44.1 K to 48.6 K (+10.21 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 28.91 | 563 | 16,276 | 44,094 | 44.7 K to 44.1 K (-1.26 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 28.91 | 1,250 | 36,138 | 44,657 | 45.9 K to 44.7 K (-2.72 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 30.75 | 563 | 17,312 | 45,907 | 46.5 K to 45.9 K (-1.21 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 30.75 | 1,250 | 38,438 | 46,470 | 47.7 K to 46.5 K (-2.62 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 5,000 | 0 | 47,720 | 42.7 K to 47.7 K (+11.70 %) |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 26.88 | 57,500 | 1,545,600 | 57,500 | |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 15,000 | 0 | 42,720 | 27.7 K to 42.7 K (+54.11 %) |
| Sep 23 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 18.48 | 750 | 13,860 | 27,555 | 28.3 K to 27.6 K (-2.65 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 18.59 | 750 | 13,943 | 28,305 | 29.1 K to 28.3 K (-2.58 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 3,000 | 0 | 29,055 | 26.1 K to 29.1 K (+11.51 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 18.59 | 750 | 13,943 | 28,305 | 29.1 K to 28.3 K (-2.58 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 3,000 | 0 | 29,055 | 26.1 K to 29.1 K (+11.51 %) |
| Jul 30 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 20.49 | 870 | 17,826 | 26,055 | 26.9 K to 26.1 K (-3.23 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 16.98 | 527 | 8,951 | 26,728 | 27.3 K to 26.7 K (-1.93 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 16.98 | 527 | 8,951 | 26,728 | 27.3 K to 26.7 K (-1.93 %) |
| Mar 09 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 15.36 | 1,790 | 27,487 | 27,255 | 29 K to 27.3 K (-6.16 %) |
| Mar 09 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 5,000 | 0 | 29,045 | 24 K to 29 K (+20.79 %) |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 9,000 | 0 | 22,500 | 13.5 K to 22.5 K (+66.67 %) |
| Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 20.07 | 1,250 | 25,088 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
| Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 20.07 | 1,250 | 25,088 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
| Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.82 | 1,250 | 24,775 | 14,750 | 16 K to 14.8 K (-7.81 %) |
| Jul 31 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Sell | S | 19.82 | 1,250 | 24,775 | 14,750 | 16 K to 14.8 K (-7.81 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
| Jul 30 2018 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jul 30 2018 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 28.58 | 65,000 | 1,857,700 | 65,000 | |
| Jul 30 2018 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1